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The objective was to assess the effect of locally administered curcumin on peripheral nerve regeneration
and functional recovery. Thirty male healthy white Wistar rats were divided into two experimental
groups (n ¼ 15), randomly: In control group (CG), the left sciatic nerve was exposed and transected
proximal to tibio-peroneal bifurcation leaving a 10-mm gap. Proximal and distal stumps were each
inserted into a silicone tube and ﬁlled with 10 mL sterilized olive oil. In treatment group (TG), the graft
was ﬁlled with 10 mL curcumin (5 mg/mL) solved in olive oil. Each group was subdivided into three
subgroups of ﬁve animals each and regenerated nerve ﬁbers were studied 4, 8 and 12 weeks after
surgery. Behavioral testing, sciatic nerve functional study, static sciatic index (SSI), gastrocnemius muscle
mass and morphometric indices conﬁrmed faster recovery of regenerated axons in TG than CG group
(p < 0.05). In immunohistochemistry, location of reactions to S-100 in TG was clearly more positive than
that in CG group. When loaded in a silicone tube, curcumin improved functional recovery and
morphometric indices of sciatic nerve. Curcumin is readily available and its local application is easily
performed without limitations of its poor bioavailability in systemic administration.
 2013 Published by Elsevier Ltd on behalf of Surgical Associates Ltd.1. Introduction
A commonly encountered clinical problem which often results
in long-term functional deﬁcit is peripheral nerve injury.1 After
complete transection, peripheral nerve regenerationwith sufﬁcient
recovery is a challenge, and treatment often results in little or no
functional recovery.2 Various techniques and agents have been
used to enhance functional recovery of peripharal nerves following
transection.3,4
Curcumin {1,7-bis (4-hydroxy-3-methoxyphenyl)-1,6-hepta
diene-3,5-dione} is a traditional spice and a bioactive coloring agent
in the rhizome of turmeric (Curcuma longa) that has been used for
centuries in Asia to treat various illnesses. Curcumin possesses vast
pharmacological properties including anti-inﬂammatory, anti-
oxidant, anti-cancer, anti-apoptotic and anti-infectious effects. Cur-
cumin canmodulate various types of the inﬂammatory cytokines and
enzymes. It has widely beneﬁcial effects as antioxidant several times
more than vitamin E.5e7 The suggestedmechanisms underlying these
protective effects are based on inhibitory actions of curcumin on: þ98 441 277 1926.
hammadi).
Elsevier Ltd on behalf of Surgical Adisease-mediated induction of inﬂammatory transcription factors,
protein kinases, adhesion molecules, oxidative stress and inﬂamma-
tion.8,9 Systemic beneﬁcial effects of curcumin on sciatic nerve crush
have already been reported.10 Bioavailability of curcumin is poor and
various approaches have also been used in attempts to improve its
bioavailability.11,12 The present study was designed to evaluate
possible local effect of curcumin onperipheral nerve regeneration in a
rat sciatic nerve transection model.
2. Materials and methods
Thirty male Wistar rats weighing approximately 300 g were divided into two
experimental groups (n ¼ 15), randomly: Control group (CG) and curcumin treated
group (TG). Each group was further subdivided into three subgroups of ﬁve animals
each and surveyed 4, 8 and 12 weeks after surgery. Twoweeks before and during the
experiments, the animals were housed in individual plastic cages with an ambient
temperature of (23  3) C, stable air humidity and a natural day/night cycle. The
rats had free access to standard rodent laboratory food and tap water. All mea-
surements were made by two blinded observers unaware of the analyzed groups.
2.1. Surgical procedure
Animals were anesthetized by intraperitoneal administration of ketamine-
xylazine (ketamine 5%, 90 mg/kg and xylazine 2%, 5 mg/kg). The procedure was
carried out based on the guidelines of the Ethics Committee of the International
Association for the Study of Pain.13 The University Research Council approved all
experiments.ssociates Ltd.
Fig. 1. BBB score for all experimental groups. Local administration of curcumin with
silicon tube grafting gave better scores than in CG group. Standard error at each data
point is shown with bars.
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nerve was exposed through a gluteal muscle incision and was 7 mm segment was
excised proximal to the tibio-peroneal bifurcation where a 10 mm gap was left due
to retraction of nerve ends. The gap was bridged using a silicone conduit, entubu-
lating 2 mm of the nerve stump at each end. The inner and outer diameters of the
tube were 2 and 6 mm, respectively. In CG the tube was ﬁlled with 10 ml sterilized
olive oil. In curcumin treated group (SigmaeAldrich Chemie GmbH, Steinheim,
Germany) the tube was ﬁlled with 10 ml curcumin (5 mg/mL) solved in olive oil. The
Curcumin we used was not solvable in saline. We used olive oil as solvent.
Accordingly in control group we used olive oil rather than saline. The animals were
anesthetized and euthanized with transcardiac perfusion of a ﬁxative containing 2%
paraformaldehyde and 1%glutaraldehyde buffer (pH 7.4) 4, 8 and 12 weeks after
surgery.
2.2. Functional assessment of reinnervation
2.2.1. Behavioral testing
Functional recovery of the nerve was assessed using the Basso, Beattie, and
Bresnahan (BBB) locomotor rating scale for rat hind limb motor function.14,15 Scores
of 0 and 21 were given when there were no spontaneous movement and normal
movement, respectively. A score of 14 shows full weight support and complete limbs
coordination. BBB recordings were performed by a trained observer who was blin-
ded to the experimental design. The testing was performed in a serene environment.
The animals were observed and assessed within a course of a 4-min exposure to an
open area of a mental circular enclosure. BBB scores were recorded once before
surgery in order to establish a baseline control and againweekly thereafter to assess
functional recovery during 12 weeks. At each time interval ﬁve animals from each
subgroup underwent Behavioral Testing.
2.2.2. Sciatic functional index (SFI)
Walking track analysis was performed 4, 8 and 12 weeks after surgery based on
the method of others.16 At each time interval ﬁve animals from each subgroup un-
derwent SFI measurement. The lengths of the third toe to its heel (PL), the ﬁrst to the
ﬁfth toe (TS), and the second toe to the fourth toe (IT) were measured on the
experimental side (E) and the contralateral normal side (N) in each rat. The sciatic
function index (SFI) of each animal was calculated by the following formula:
SFI ¼ 38:3 ðEPL  NPLÞ=NPL þ 109:5 ðETS NTSÞ=NTSþ 13:3
ðEIT NITÞ=NIT 8:8
In general, SFI oscillates around 0 for normal nerve function, whereas
around 100 SFI represents total dysfunction. SFI was assessed in the NC group and
the normal level was considered as 0. SFI was a negative value and a higher SFI
meant the better function of the sciatic nerve.
2.2.3. Static sciatic index (SSI)
SSI is calculated using the static factors, not considering the print length factor
(PL), according to the equation:
SSI ¼ ½ð108:44 TSFÞ þ ð31:85 ITSFÞ  5:49
where:
TSF ¼ (ETS  NTS)/NTS
ITSF ¼ (EIT  NIT)/NIT
At each time interval ﬁve animals from each subgroup underwent SSI mea-
surement. Like SFI, an index score of 0 was considered normal and an index of 100
indicated total impairment. When no footprints were measurable, the index score
of 100 was given.17
2.3. Muscle mass
Recovery assessment was also indexed using the weight ratio of the gastroc-
nemius muscles 12 weeks after surgery. Immediately after sacriﬁcing of animals,
gastrocnemius muscles were dissected and harvested carefully from intact and
injured sides and weighed while still wet, using an electronic balance. At each time
interval ﬁve animals from each subgroup had muscle mass measurement.
2.4. Histological preparation and morphometric studies
Nerve mid-substance in experimental groups were harvested and ﬁxed with
glutaraldehyde 2.5%. They were post ﬁxed in OsO4 (2%, 2 h), dehydrated through an
ethanol series and embedded in Epon. The nerves were cut in 5 mm in the middle,
stained with toluidine blue and examined under light microscopy. Morphometric
analysis was carried out using an image analyzing software (Image-Pro Express,
version 6.0.0.319, Media Cybernetics, Silver Springs, MD, USA). Equal opportunity,
systematic random sampling and two-dimensional dissector rules were followed in
order to cope with sampling-related, ﬁber-location-related and ﬁber-size relatedbiases.18 The parameters assessed in histological studies included number of nerve
ﬁbers, diameter of nerve ﬁbers, diameter of axons, thickness of myelin sheath and G
ratio.
2.5. Immunohistochemical analysis
In this study, anti-S-100 (1:200, DAKO, USA) was used as marker for myelin
sheath. Specimens were post ﬁxedwith 4% paraformaldehyde for 2 h and embedded
in parafﬁn. Prior to immunohistochemistry nerve sections were dewaxed and
rehydrated in PBS (pH 7.4). Then the nerve sections were incubated with 0.6%
hydrogen peroxide for 30 min. To block non-speciﬁc immunoreactions the sections
were incubated with normal swine serum (1:50, DAKO, USA). Sections were then
incubated in S-100 protein antibody solution for 1 h at room temperature. Theywere
washed three times with PBS and incubated in biotynilated anti-mouse rabbit IgG
solution for 1 h. Horseradish peroxidase-labeled secondary antibody was applied for
1 h. After that all sections were incubated with 3,30- diaminobenzidine tetrahy-
drochloride chromogene substrate solution (DAB, DAKO, USA) for 10min. The results
of immunohistochemistry were examined under a light microscope.
2.6. Statistical analysis
The results were expressed as means  SD. Statistical analyses were performed
using PASW 18.0 (SPSS Inc., Chicago, IL, USA). Model assumptions were evaluated by
examining the residual plot. Results were analyzed using a factorial ANOVAwith two
between-subjects factors. Bonferroni test for pairwise comparisons was used to
examine the effect of time and treatments. The differences were set at P < 0.05.
3. Results
3.1. BBB recovery
Fig. 1 shows BBB scores compared to the baseline. All experi-
mental groups showed the greatest degree of functional deﬁcit one
week after surgery. The curcumin treated group showed signiﬁcant
improvement in locomotion of the operated limb compared to the
CG group during the study period (P < 0.05).
3.2. Recovery of sciatic nerve function and reinnervation
3.2.1. SFI outcome
Fig. 2 shows sciatic function index (SFI) values in experimental
groups. Prior to surgery, SFI values in both groups were near zero.
After the nerve transection, the mean SFI decreased to 100 due to
the complete loss of sciatic nerve function in all animals. At the end
of the study period, animals of curcumin group achieved a mean
value for SFI of 41.2  2.49 whereas in group CG a mean value
of 57.4  5.12 was found. The statistical analyses revealed that
the recovery of nerve functionwas signiﬁcantly (P < 0.05) different
Fig. 2. Bar graph indicating sciatic nerve function index (SFI) values in each experi-
mental group during the study period. Local administration of curcumin with silicone
tube gave better results in functional recovery of the sciatic nerve than in CG group.
Data are presented as mean  SD. *P < 0.05 vs CG group.
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silicone tube signiﬁcantly improved functional recovery in the
course of time.
3.2.2. SSI outcome
Changes in SSI were similar to those observed in SFI, indicating
signiﬁcant deﬁcit following the sciatic nerve transection (Fig. 3).
Changes in SSI were signiﬁcant at weeks 4, 8 and 12 weeks of re-
covery (P < 0.05). The contrasts indicated SSI values at week 12 toFig. 3. Bar graph indicating static sciatic index (SSI) values in each experimental group
during the study period. Local administration of curcumin with silicone tube gave
better results in functional recovery of the sciatic nerve than in CG group. Data are
presented as mean  SD. * P < 0.05 vs CG group.differ signiﬁcantly from those obtained from CG, a trend also
noticed for SFI (P < 0.05).
3.3. Muscle mass measurement
The mean ratios of gastrocnemius muscle weight were
measured at the end of the study period. Mean weight of the
gastrocnemius muscle for animals of the control and treatment
groups were 0.7  0.09 and 1.24  0.12, respectively. There was a
statistically signiﬁcant difference between themuscle weight ratios
of the TG and CG groups (P< 0.05). Because of an increase inmuscle
mass the TG group, muscle had been reinnervated and ﬁber
diameter has been increased, leading to an increase in cross-
sectional area. The results showed that in the curcumin treated
group weight loss in the gastrocnemius muscle was ameliorated by
curcumin local administration (Fig. 4).
3.4. Histological and morphometric ﬁndings
Table 1 shows quantitativemorphometric analyses of regenerated
nerves for each of the experimental groups. Statistical analysis by
means of a one-way ANOVA test showed that the increase in number
of ﬁbers, diameter of ﬁbers and diameter of axons, as well as increase
inmeanmyelin thickness in the ﬁrst 4 weeks of the study periodwas
statisticallysigniﬁcant inbothgroups (P>0.05).On thecontrary, 8and
12 weeks after surgery no signiﬁcant difference in mean thickness of
myelin sheath was observed between groups (P < 0.05), however,
therewas signiﬁcant difference innumber ofﬁbers, diameter ofﬁbers
and diameter of axons between two experimental groups.
Using Factorial ANOVA analysis with two between-subjects
factors (Group  time); inside the TG group myelin thickness did
not show a signiﬁcant difference between 8 and 12 weeks
(P > 0.05). The thickness of myelin sheaths showed an interaction
across time in both groups. An increase in mean thickness of myelin
sheaths was not statistically different between 8 and 12 weeks
inside each group (P > 0.05).
3.5. Immunohistochemistry
Immunoreactivity to S-100 protein was extensively observed in
the cross sections of regenerated nerve segments. The expression of
S-100 protein signal was located mainly in the myelin sheath. TheFig. 4. Gastrocnemius muscle weight measurement. The gastrocnemius muscles of
both sides (operated left and unoperated right) were excised and weighed in the
experimental groups at 12 weeks after surgery. Data are presented as mean  SD. *
P < 0.05 vs CG group.
Table 1
Morphometric analyses of regenerated nerves for each of the experimental groups: values are given as mean  SD.
Weeks TG CG
4 8 12 4 8 12
N 3126  259 4037  283 6231  225 1714  289a 3145  281a 3723  264a
D 7.73  0.34 9.69  0.53 10.21  0.78 3.73  0.76a 7.95  0.42a 8.97  0.53a
d 4.49  0.39 5.93  0.71 6.52  0.37 2.88  0.65a 4.45  0.73a 87.87  0.5a
T 1.67  0.06 2.56  0.36 2.61  0.48 0.62  0.11a 2.68  0.39 2.32  0.33
G-ratio 0.58 0.61 0.63 0.77 0.55 0.55
N: Number of ﬁbers D: Diameter of ﬁbers (mm) d: Diameter of axon (mm) T: Thickness of myelin sheath (mm).
a The mean difference is signiﬁcant at the 0.05 level.
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like phenotype existed around the myelinated axons (Fig. 5). In
both TG and CG groups, the expression of S-100 and the ﬁndings
resembled those of the histological evaluations.Fig. 5. Immunohistochemical analysis of the regenerated nerves. Representative cross secti
midpoint of TG (DeF) 4, 8 and 12 weeks after surgery, respectively. There was clearly mor
periphery of nerve, indicating well organized structural nerve reconstruction in curcumin4. Discussion
The design of the present study was a sciatic nerve transection
model in rat. In regenerative medicine tissue loss is the moston taken from midpoint of CG (AeC) 4, 8 and 12 weeks after surgery, respectively, and
e positive staining of the myelin sheath-associated protein S-100 (arrows) within the
treated nerve compared to that of the CG during study period. Scale bar: 10 mm.
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Using autograft as a gold standard is still ongoing in peripheral
nerve repair. Since the present study was designed to assess
entubulation neurorrhaphy combined with local curcumin
administration as an alternative method, no nerve autograft group
was considered in experimental design. In the present study, cur-
cumin, a natural phenolic compound, was evaluated for its ability to
locally improve regeneration of transected sciatic nerve. The results
showed that application of curcumin in a silicone tube resulted in
faster improvement functional recovery of the sciatic nerve during
the study period. Left gastrocnemius muscle weight was signiﬁ-
cantly greater in the TG group than in the CG group, indicating
indirect evidence of successful end organ reinnervation in the
curcumin treated animals. Four weeks after surgery morpho-
metrical indices showed signiﬁcant improvement in curcumin
treated group. At weeks 8 and 12 quantitative morphometrical
indices of regenerated nerve ﬁbers showed signiﬁcant differences
between the TG and CG groups, indicating a beneﬁcial effect of local
application of curcumin on the nerve regeneration. The Curcumin
we used was not solvable in saline. Hence, we used olive oil as a
solvent. Accordingly in control group we used olive oil rather than
saline. Compared to our other study 19 no comparable difference
was observed between saline and olive oil ﬁlled groups. Regarding
this comparison neither positive nor negative effect of olive oil was
observed during the study period.
Bothmorphological and functional data have been used to assess
neural regeneration after induced crush injuries, the correlation
between these two types of assessment is usually poor.20e22 Classical
andnewlydevelopedmethodsof assessingnerve recovery, including
histomorphometry, retrograde transport of horseradish peroxidase
and retrograde ﬂuorescent labeling23,24 do not necessarily predict
the reestablishment of motor and sensory functions.22,25e27
Although such techniques are useful in studying the nerve regener-
ation process, they generally fail in assessing functional recovery.22
Therefore, research on peripheral nerve injury needs to combine
both functional and morphological assessment. Castaneda et al.,28
suggested that arrival of sprouts from the proximal stump at the
distal nerve stump does not necessarily imply recovery of nerve
function. BBB is widely used to assess functional recovery in spinal
cord injured animals, however, it has been demonstrated that it
could be most useful in assessment of never repair processes in pe-
ripheral nerve injuries15 and information taken from BBB scale may
be invaluable in evaluation of peripheral nerve process. In order to
assess hind limb recovery the open ﬁeld locomotor was used and
results of the present study showed that the curcumin treated ani-
mals had been improved in locomotion of the operated limb
compared to the CG group during the study period. Walking track
analysis and static sciatic index has frequently been used to reliably
determine functional recovery following nerve repair in rat
models.16,17,26 Static sciatic index is a time-saving digitized static
footprint analysis and, a goodcorrelationbetween the traditional SFI,
the newly developed static sciatic index (SSI) has been reported.29
The Static sciatic index is an easy technique for accurate functional
assessment of peripheral nerve regeneration in rats. The present
study again showed similar results taken from both SFI and SSI as-
sessments. However, no signiﬁcant difference was observed in
myelin thickness between two groups indicating that selection of a
reliable technique for nerve repair assessment is crucial.
Regenerated rat peripheral nerve ﬁbers are not able to return
spontaneously to their normal pretrauma state, therefore neuro-
protective factors combined with nerve entubulization have been
used to accelerate nerve regeneration.30e32 Growth factors are
members of family of neurotrophic factors that support and inﬂu-
ence the growth and regenerative capacity of neurons. These sub-
stances are produced by a number of tissues during developmentand direct the formation of the brain and spinal cord and their
connections to target organs such as muscle. Nerve growth factor
has been demonstrated that promotes nerve regeneration.32e36
Curcumin has anti-inﬂammatory and antioxidants properties.
Curcumin is able to modulate the regulation of the inﬂammatory
cytokines such as IL-6, TNF and COX-2.5 Curcumin is also a good
scavengerof the reactiveoxygenspecies and is suggested tobeagood
neuroprotectant. It canpass through the blood brain barrier, which is
an evidence of ampliﬁcation of its neuroprotectant potential in
neurodegenerative disorders such as Parkinson’s and Alzheimer’s
diseases.6 In addition, it has been reported that curcumin has pro-
tective effects after spinal cord injuries. The previous studies have
stressed the anti-apoptotic effects of the curcumin on the neurons.37
Curcumin has a variety of pharmacologic effects including acts
as a neuroprotective agent in several neurologic diseases.9 For
example, curcumin inhibited neuronal cell death from dopami-
nergic neurotoxicity, apparently through the inhibition of c-Jun N-
terminal kinase pathway, and it also protected the brain from I/R-
induced neuronal damage by increasing the antioxidant system
and decreasing oxidative stress.38e40
Despite the multiple pharmacological effects and the Phase I clin-
ical safety even at high doses (12 g/day), curcumin has poor in vivo
bioavailability, as demonstrated by its low serum levels and limited
tissue distribution.41e44 Numerous studies have evaluated the level of
curcuminafteradministrationand found thateithernocurcuminor its
metabolites, or only low levels, were detected in serum or tissue.45e48
Curcumin given orally undergoes conjugation, resulting in curcumin
glucuronide and sulfates. Curcumin administered intraperitoneally or
systemically undergoes reduction to generate tetrahydrocurcumin,
hexahydrocurcumin and octahydrocurcumin.49,50 In addition to the
poor bioavailability, curcuminmetabolites that are the result of either
conjugationor reductionhavebeen foundtobebiologically inactiveby
most studies.51e53 Our other work investigating systemic effects of
curcumin on transected nerve regeneration (unpublished data) sup-
ports the poor bioavailability of curcumin. It has been conﬁrmed that
the most efﬁcient means of delivering curcumin to cells is via incor-
poration in to liposomes.54 In a wound healing study Curcumin
treatment resulted in enhancedﬁbronectin and collagenexpression.55
Others demonstrated that the viscous collagen gel containing laminin
and ﬁbronectin can provide a potential promoting effect on the
regeneration of dissected nerves in the silicone rubber tubes.56 The
mentioned mechanisms could be considered as a rationale for signif-
icantly improved and accelerated nerve regeneration in locally used
curcumin in the present study.
Even though our preliminary study shows the neuroprotective
action of local curcumin in peripheral nerve injuries, data regarding
the molecular mechanisms leading to the neuroprotective action in
transected models is limited. We have not given the histological
and molecular evidence for neuroprotective action of curcumin.
This may be considered as a limitation to our study. Therefore, the
authors stress that the aim of the current investigation was to
evaluate a single local dose and clinical treatment potential of
curcumin on nerve regeneration. Mechanism of neuroprotective
action remains to be investigated.
Others10 used dosage of 100 mg/kg for curcumin in intraperi-
toneal administration in a crush model study. In local application
we used a reduced dosage (5 mg/mL) in our study design. Thus,
dose response studies should be conducted for curcumin to
determine the combination of the graft and the compound that
achieve maximal efﬁcacy in nerve transection models.
5. Conclusion
The present study demonstrated that local application of cur-
cumin could accelerate and improve functional recovery after
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ORIGINAL RESEARCHtransection of sciatic nerve. Curcumin is readily available and its
local application is easily performed without limitations of its poor
bioavailability in systemic and oral administration.
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